Model-based evaluation of the cost effectiveness of 3 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

by Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
Published 2020-09-01

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients

by Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
Published 2021-03-01